| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |